INDIA – PharmaLytica at BEC, Mumbai is the leading conference that provides latest industry trends innovations, Pharma Machinery and Ingredients opportunities this June 1-3.
Esco Aster alongside with Saksham Scientific will gather to exhibit the proprietary CelCradle® Tide Motion bioreactor and the BioNOC™II macrocarriers in full view. The team is set on providing pharmaceutical needs in terms of these upstream bioprocessing tools. CelCradle® is a single-use bioreactor designed for adherent cells. It is suitable for small-scale research production as well as a seed train for scaling up to manufacturing or pilot system (TideXcell®). These bioreactors utilize Tide Motion principle, that provides a gentle upward and downward motion of the culture media to provide extremely low shear stress environment for the cells.
What about efficiency? Tide Motion bioreactors have a competitive system advantage, especially the 100% media exchange configuration that works best when doing viral culture work to produce higher viral titers or for stem cell culture, which requires switching to a different media for differentiation.
Esco Aster and Saksham Scientific have much more to at this highly anticipated event in Mumbai. It will undoubtedly cater your organization’s needs and allow you to network and meet potential collaborators for your next pharmaceutical developments.
Be sure not to miss out on this amazing opportunity to connect with India’s pharma community at hall 1, booth F12.
Click here to register at PharmaLytica 2022.
Esco Aster is a vertically-integrated contract research (CRO), contract development and manufacturing organization (CDMO) founded and deeply rooted by scientists enabling fellow scientists to translate their bench work into life-saving diagnostics, medicines, therapies, cosmeceuticals, and cellular agriculture, at affordable prices for self-sufficiency of the country. We make complex manufacturing simple via our proprietary best-in-class continuous manufacturing platforms providing a reliable and linearly scalable outcome. Learn more at www.escoaster.com and connect with Esco Aster on LinkedIn.